fertility-health
Thyroid Disorders and Fertility: How Hypothyroidism and Hyperthyroidism Affect Conception
Dr. Carolina Gallardo
Secondary Infertility
Secondary infertility — difficulty conceiving after a prior successful pregnancy — affects nearly as many couples as primary infertility and deserves the same thorough evaluation.
Affects approximately 3–4 million couples in the United States; ~11% of couples who have had a prior live birth
Defined as the inability to conceive or carry a pregnancy to term after previously achieving a live birthAge-related egg quality decline is the most common cause — the interval since the last pregnancy is often the defining factorNew-onset conditions including endometriosis, fibroids, and diminished ovarian reserve frequently develop in the interval between pregnanciesMale factor changes — including new varicocele, testosterone use, or interval health changes — account for a significant proportion of secondary infertility casesThe emotional burden of secondary infertility is often underrecognized — couples report feeling dismissed, isolated, and invalidated by a system that assumes prior parenthood means fertility
Find Clinics That Specialize in Secondary InfertilityHow Secondary Infertility Affects Fertility
Secondary infertility is defined as difficulty conceiving or maintaining a pregnancy after previously achieving a live birth with the same or a different partner. The standard diagnostic criteria — failure to conceive after 12 months of regular unprotected intercourse (or 6 months for women over 35) — apply equally to secondary infertility, though many couples and even clinicians delay evaluation because of the assumption that prior success guarantees continued fertility. This delay is clinically harmful: the most common cause of secondary infertility is age-related decline in egg quality, and time is the one resource that cannot be recovered.
The interval since the last successful pregnancy is the most important variable in secondary infertility. Ovarian reserve declines continuously with age — AMH falls approximately 0.2 ng/mL per year on average after age 30, with steeper decline after 35. A couple who conceived at age 30 may find that by age 37, egg quality and reserve have declined significantly enough to prevent natural conception despite identical circumstances. New-onset reproductive conditions also develop in the interval between pregnancies: endometriosis progresses, uterine fibroids grow and may now distort the cavity, intrauterine adhesions (Asherman syndrome) can form after uterine procedures, thyroid disease can emerge, and ovulatory dysfunction can develop. The evaluation for secondary infertility must therefore be comprehensive — it cannot be abbreviated based on prior fertility success.
Male factor changes are a frequently overlooked cause of secondary infertility. Lifestyle changes such as anabolic steroid use, obesity, tobacco, or new medications can significantly impair semen parameters. Testicular injury, varicocele development, and new hormonal disorders (e.g., pituitary adenoma causing elevated prolactin) can emerge between pregnancies. A new semen analysis is essential in secondary infertility evaluation, regardless of prior fertility. Psychologically, secondary infertility carries a unique burden: couples are often told to feel grateful for the child they have, while genuine grief about an unachieved desired family size is minimized. Support groups and psychological counseling addressing this specific experience are an important component of comprehensive care.
Treatment Options
Treatment is individualized based on age, severity, duration of infertility, and partner factors. Work with your reproductive endocrinologist to determine the right sequence for your specific situation.
First-line treatment
Comprehensive Re-evaluation (Both Partners)
The first step in secondary infertility is a complete, current fertility workup — not an abbreviated one. For women: ovarian reserve testing (AMH, AFC, day-3 FSH), transvaginal ultrasound to assess the uterus and ovaries, evaluation of the uterine cavity (saline sonohysterogram or hysteroscopy), tubal patency assessment (HSG if indicated), thyroid function, and prolactin. For men: a new semen analysis, regardless of prior normal results or paternity. Many couples with secondary infertility will have a new, identifiable, and treatable cause detected at this evaluation.
First-line treatment
Ovulation Induction (Letrozole or Clomiphene)
For women with secondary infertility due to new-onset anovulation (PCOS, thyroid dysfunction, hyperprolactinemia), ovulation induction with letrozole (2.5–7.5 mg on days 2–6) is the first-line treatment per ASRM 2023 guidelines. As in primary infertility, letrozole is preferred over clomiphene for PCOS-associated anovulation based on the NICHD PPCOS II trial. Underlying thyroid or prolactin disorders should be treated medically before initiating ovulation induction.
Typical success rate
27–40% live birth per ovulatory cycle (letrozole); as per primary infertility data — secondary infertility-specific data are limited
Intrauterine Insemination (IUI)
IUI with ovulation induction is an appropriate first-line ART step for secondary infertility when the cause is mild male factor, unexplained, or mild anovulation in women with patent tubes. Per-cycle success rates and the recommended 3–6 cycle trial before IVF escalation apply equally to secondary infertility. IUI is less effective for women over 38 or those with diminished ovarian reserve, for whom IVF is preferred.
Typical success rate
8–15% per cycle; cumulative 35–50% over 3–6 cycles (age < 38)
IVF (In Vitro Fertilization)
IVF is indicated for secondary infertility when a specific cause warrants it (bilateral tubal occlusion, severe male factor, significant diminished ovarian reserve) or when other treatments have failed. Success rates in secondary infertility parallel those in primary infertility for the same age and diagnosis — prior pregnancy does not confer a meaningful advantage in IVF cycle outcomes, as the current egg cohort and uterine environment are what matter. Women over 38 with secondary infertility should move to IVF more quickly given the steeper age-related decline in egg quality.
Typical success rate
35–50% live birth per transfer for women under 38 with secondary infertility (SART 2022 data; varies by diagnosis)
Surgical Treatment of Identified Structural Causes
Secondary infertility due to Asherman syndrome (intrauterine adhesions — often from a prior D&C or uterine surgery), new submucosal fibroids, uterine polyps, or a uterine septum should be treated by hysteroscopic surgery before pursuing fertility treatment. Laparoscopy for new-onset endometriosis or tubal adhesions may be appropriate in selected patients. Prior successful pregnancy does not protect against the development of these conditions, and their timely correction may restore natural fertility without requiring ART.
What Patients with Secondary Infertility Can Expect
Success rates for secondary infertility treatment mirror those of primary infertility when matched for age, diagnosis, and treatment type. The most important prognostic factor is current maternal age, not the age at which the prior pregnancy occurred. Couples with secondary infertility due to age-related DOR have lower success rates with own eggs than younger couples; those with a newly identified and treatable structural cause often have excellent outcomes after surgery.
| Treatment | Typical Success Range |
|---|---|
| Letrozole + IUI (anovulatory secondary infertility, age < 38) | 10–15% per cycle; 35–50% cumulative over 3–6 cycles |
| IVF (secondary infertility, age < 35) | 40–55% live birth per transfer |
| IVF (secondary infertility, age 35–40) | 25–40% live birth per transfer |
| Hysteroscopic surgery (Asherman/polyp/fibroid) | Highly variable; 50–80% in observational series after Asherman treatment |
Individual outcomes vary significantly based on age, ovarian reserve, partner factors, and clinic expertise. These figures are based on published research (ASRM, SART, Cochrane Reviews) and national averages — they are not guarantees. Ask your clinic for their own reported outcomes for your specific diagnosis and age group.
Questions to Ask Your Reproductive Endocrinologist
Bring this list to your first consultation to make the most of your appointment.
- 1
Has my fertility workup been updated since my last pregnancy — including ovarian reserve testing and a new semen analysis for my partner?
- 2
Could any procedures I had after my last delivery (D&C, uterine surgery) have caused intrauterine scarring (Asherman syndrome)?
- 3
Is my difficulty conceiving likely due to age-related egg quality decline, and how does that affect our treatment options?
- 4
Do I have any new conditions — fibroids, endometriosis, thyroid disease — that were not present in my prior pregnancy?
- 5
How quickly do you recommend escalating to IVF given my current age?
- 6
Are there support resources specifically for secondary infertility that you can recommend?
When to See a Specialist
Couples experiencing secondary infertility should see a reproductive endocrinologist after 12 months of trying (6 months if the woman is over 35, 3 months if over 40). Do not wait longer because of a prior successful pregnancy — age-related decline continues regardless of prior fertility. If there has been a prior pregnancy loss in the interval, evaluation should begin promptly for both infertility and recurrent pregnancy loss.
Ready to Find a Clinic That Specializes in Secondary Infertility?
Look for clinics with reproductive endocrinologists (REs) who have documented experience treating Secondary Infertility. Ask about their specific outcomes for your diagnosis and age group during your first consultation — outcomes vary significantly by clinic.
Select your state to browse fertility clinics near you:
Related Articles
IVF
Beta hCG After IVF: What Your First Result Means
Your first beta hCG result after IVF is one of the most nerve-wracking numbers in the entire process. This guide explains what it means, what doubling times to expect, how to interpret a borderline result, and what comes next.
Dr. Hannah Ní Bhriain Russell
IVF
OHSS After IVF: Symptoms, Classification, Prevention & Treatment
Ovarian hyperstimulation syndrome is the most serious complication of IVF stimulation. This guide covers who is at risk, how severity is graded, evidence-based prevention strategies, and what to do if symptoms develop.
Dr. Hannah Ní Bhriain Russell
IVF
ICI vs IUI vs IVF: Which Treatment Should You Start With?
The right starting point for fertility treatment is never the same for everyone — it depends entirely on your diagnosis. This guide gives you a clear, evidence-based framework for deciding between ICI, IUI, and IVF.
Prof. Jane Harries
Related Conditions
Endometriosis
Affects ~10% of reproductive-age women; up to 50% of infertile women
Learn moreUnexplained Infertility
Diagnosed in 15–30% of infertile couples after standard evaluation
Learn moreDiminished Ovarian Reserve (DOR)
Affects approximately 10–30% of women who present for fertility evaluation
Learn moreRecurrent Pregnancy Loss (RPL)
Affects 1–2% of couples; recurrence risk rises sharply after 3 or more losses
Learn moreUterine Fibroids & Fertility
Affect up to 70–80% of women by age 50; fertility-impairing fibroids present in 5–10% of infertile women
Learn more